Search Results 191-200 of 17393 for Oncogene

  1. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    Oncogene. 2013; doi:10.1038/onc.2012.628. Ingle JN, et al. Estrogens and their precursors in postmenopausal women with early breast cancer receiving ...

  2. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    Oncogene. 2013; doi:10.1038/onc.2012.628. Ingle JN, et al. Estrogens and their precursors in postmenopausal women with early breast cancer receiving ...

  3. Publications - Benjamin R. Kipp, Ph.D. - Mayo Clinic

    ... oncogenic transformation of juxtaglomerular cells to juxtaglomerular cell tumors. Hum Pathol. 2025 Nov; 165:105939 Epub 2025 Sept 29. View PubMed; Huynh V ...

  4. Medical Research & Education - Mayo Clinic News Network

    Cancer. Mayo Clinic Researchers Find Two Oncogenes Join to Drive Lung Squamous Cell Carcinoma. Kevin Punsky. February 10, 2014. Infectious Diseases. When Cats ...

  5. Study of mouse gut microbiome may provide clues to how cancer develops in humans - Mayo Clinic News Network

    "In our study we were able to show that oncogenic mammary cells behave differently in animals with and without germs," says Dr. Kannan. "Cancer cells ...

  6. Publications - Cliff Shin, M.D., Ph.D. - Mayo Clinic

    Oncogene. 2017 Aug 10; 36 (32):4610-4618 Epub 2017 Apr 03. View PubMed; Shin CH, Grossmann AH, Holmen SL, Robinson JP. The BRAF kinase domain promotes the ...

  7. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Researchers Find Two Oncogenes Join to Drive Lung Squamous Cell Carcinoma. Kevin Punsky. February 10, 2014. First · Previous ... 338 · 339 · 340 ...

  8. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Researchers Find Two Oncogenes Join to Drive Lung Squamous Cell Carcinoma. Kevin Punsky. February 10, 2014. Infectious Diseases. When Cats Bite: 1 ...

  9. AI-driven drug discovery - Microenvironments and Applied Nanomedicine Laboratory - Mayo Clinic Research

    ... oncogenic signaling. Preclinical studies demonstrated that GIPCi significantly suppressed tumor growth, enhanced the efficacy of gemcitabine, remodeled the ...

  10. Peter Storz, Ph.D. - Mayo Clinic Faculty Profiles

    In the presence of an oncogenic KRAS mutation, cells that have undergone acinar-to-ductal metaplasia progress to pancreatic intraepithelial neoplasia and ...